The pathobiology of splicing.

The Journal of Pathology
Amanda J Ward, Thomas A Cooper

Abstract

Ninety-four percent of human genes are discontinuous, such that segments expressed as mRNA are contained within exons and separated by intervening segments, called introns. Following transcription, genes are expressed as precursor mRNAs (pre-mRNAs), which are spliced co-transcriptionally, and the flanking exons are joined together to form a continuous mRNA. One advantage of this architecture is that it allows alternative splicing by differential use of exons to generate multiple mRNAs from individual genes. Regulatory elements located within introns and exons guide the splicing complex, the spliceosome, and auxiliary RNA binding proteins to the correct sites for intron removal and exon joining. Misregulation of splicing and alternative splicing can result from mutations in cis-regulatory elements within the affected gene or from mutations that affect the activities of trans-acting factors that are components of the splicing machinery. Mutations that affect splicing can cause disease directly or contribute to the susceptibility or severity of disease. An understanding of the role of splicing in disease expands potential opportunities for therapeutic intervention by either directly addressing the cause or by providing novel appro...Continue Reading

References

Jan 1, 1992·Human Mutation·P Shelbourne, K Johnson
Oct 1, 1990·Journal of the Neurological Sciences·E P HoffmanT A Partridge
Jan 1, 1993·Nature Genetics·J F MercerD Siemieniak
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·B M DavisD E Housman
Mar 18, 1999·Advances in Experimental Medicine and Biology·Z TümerN Horn
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·I D'SouzaG D Schellenberg
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·C L LorsonB Wirth
Aug 18, 1999·Proceedings of the National Academy of Sciences of the United States of America·K GeG C Prendergast
Aug 1, 2000·Trends in Biochemical Sciences·C W Smith, J Valcárcel
Feb 17, 2001·American Journal of Human Genetics·S A SlaugenhauptJ F Gusella
Feb 17, 2001·American Journal of Human Genetics·S L AndersonB Y Rubin
Aug 31, 2001·Progress in Neurobiology·C A Grimes, R S Jope
Nov 21, 2001·The Journal of Biological Chemistry·Nicola A HawkesJesper Q Svejstrup
Feb 11, 2003·American Journal of Human Genetics·Math P CuajungcoSusan A Slaugenhaupt
Feb 26, 2003·Genes & Development·Nuno André Faustino, Thomas A Cooper
Apr 16, 2003·European Journal of Biochemistry·Jens Kurreck
Jul 2, 2003·Nature Genetics·Tsuyoshi Kashima, James L Manley
Oct 28, 2003·Human Genetics·Gloria Hsi, Diane W Cox
Dec 13, 2003·Science·Rahul N KanadiaMaurice S Swanson
Aug 3, 2004·Nature Reviews. Cancer·Hitoshi Okada, Tak W Mak
Sep 1, 2004·Cellular and Molecular Life Sciences : CMLS·C AkgulS W Edwards
Oct 28, 2004·The Journal of Molecular Diagnostics : JMD·Christopher L CorlessMichael C Heinrich

❮ Previous
Next ❯

Citations

Mar 1, 2012·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Daniel WysokinskiJacek P Szaflik
Sep 2, 2011·Journal of Molecular Neuroscience : MN·Payal RayJane Y Wu
Feb 25, 2011·ACS Chemical Biology·Liying FanPhilip M Potter
Oct 18, 2012·Organic Letters·Reymundo VillaMichael D Burkart
Oct 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Francesca ZammarchiLuca Cartegni
Feb 26, 2011·The Journal of Biological Chemistry·Amelia MazzoneGianrico Farrugia
May 6, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Carol J GallioneDouglas A Marchuk
Mar 29, 2011·Cold Spring Harbor Perspectives in Biology·Cindy L Will, Reinhard Lührmann
Nov 3, 2010·Molecular and Cellular Biology·Christine M Misquitta-AliBenjamin J Blencowe
Sep 26, 2012·Journal of Nucleic Acids·Jill A DembowskiPaula J Grabowski
Dec 22, 2010·BMC Genomics·Yizhen JiaDavid K Smith
Jul 3, 2013·BMC Cancer·Livia MaccioniRajiv Kumar
Dec 24, 2011·Journal of Cell Science·Alok SharmaPaula A Bubulya
Aug 13, 2013·International Journal of Cell Biology·Claire JacksonAlison Tyson-Capper
Jul 12, 2014·PloS One·Zhaleh N AminiUlrich F Müller
Dec 5, 2009·The Journal of Pathology·Peter A HallRichard Poulsom
May 20, 2015·Neurogenetics·Valentina La CognataSebastiano Cavallaro
Dec 2, 2011·Journal of Nucleic Acids·Sophie GermannDidier Auboeuf
Feb 11, 2014·TheScientificWorldJournal·Zorka MilićevićBiljana Spremo-Potparević
Dec 14, 2011·Blood·Virginia M Klimek
Jun 28, 2016·Brain : a Journal of Neurology·Megan S KaneBenjamin D Solomon
Jun 19, 2016·BMC Endocrine Disorders·Pattaranatcha CharnwichaiVorasuk Shotelersuk
Apr 17, 2013·Neurobiology of Aging·Silvia BianchiAntonio Federico
Aug 23, 2012·Gene·Olga KelemenStefan Stamm
Dec 21, 2016·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Stephen J BushAraxi O Urrutia
Dec 24, 2016·International Journal of Molecular Sciences·Maria Valeria EspositoFrancesco Salvatore
Feb 2, 2017·International Journal of Molecular Sciences·Barbara RizzacasaFrancesca Amati
Mar 2, 2017·Genes·Marc Suñé-PouCarlos Suñé

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Related Papers

Methods : a Companion to Methods in Enzymology
Thomas A Cooper
Postepy biochemii
Hanna WiszomirskaAlicja Nauman
Proceedings of the National Academy of Sciences of the United States of America
El Chérif IbrahimTom Maniatis
Yi chuan xue bao = Acta genetica Sinica
Guo-Wei ZhangZhu Chen
© 2022 Meta ULC. All rights reserved